MICARDIS telmisartan 80mg tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

telmisartan, Quantity: 80 mg

Mevcut itibaren:

Boehringer Ingelheim Pty Ltd

Farmasötik formu:

Tablet, uncoated

Kompozisyon:

Excipient Ingredients: magnesium stearate; povidone; sodium hydroxide; sorbitol; meglumine

Uygulama yolu:

Oral

Paketteki üniteler:

98 tablets, 7 tablets, 28 tablets, 56 tablets

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

MICARDIS is indicated for:,?Treatment of hypertension in adults,?Prevention of cardiovascular morbidity and mortality in adults 55 years or older withcoronary artery disease, peripheral artery disease, previous stroke, transient ischaemicattack or high risk diabetes with evidence of end organ damage (see Section 5.1Pharmacodynamic Properties, Clinical trials)

Ürün özeti:

Visual Identification: White to off-white, oblong tablet one face marked with "52H" and the other face marked with the Boehringer Ingelheim company symbol.; Container Type: Blister Pack; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

1999-08-27

Bilgilendirme broşürü

MICARDIS
®
_TABLETS_
_telmisartan_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Micardis.
It does not contain all available
information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have benefits and
risks. Your doctor has weighed the
risks of you taking this medicine
against the benefits it is expected to
have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
This leaflet was last updated on the
date at the end of this leaflet. More
recent information may be available.
The latest Consumer Medicine
Information is available from your
pharmacist, doctor, or from
www.medicines.org.au and may
contain important information about
the medicine and its use of which
you should be aware.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT MICARDIS IS USED
FOR
Micardis is used to:
•
treat high blood pressure (also
called hypertension)
•
prevent cardiovascular
complications, including death
due to cardiovascular causes, in
patients older than 55 years of
age with coronary artery disease,
peripheral vascular disease,
previous stroke, previous
transient ischaemic attack (TIA)
or high risk diabetes with
evidence of end organ damage.
TREATMENT OF HYPERTENSION
Micardis is used to lower high blood
pressure (hypertension).
Everyone has blood pressure. This
pressure helps your blood move
around your body. Your blood
pressure may be different at different
times of the day, depending on how
busy or worried you are. You have
hypertension (high blood pressure)
when your blood pressure stays
higher than normal, even when you
are calm or relaxed.
There are usually no signs of
hypertension. The only way of
knowing that you have hypertension
is to have your blood pressure
checked on a regular basis. If high
blood pressure is not treated, it can
lead to serious health problems,
including stroke, heart disease and
kidney failure.
_HOW MICARDIS WORKS_
Micardis contains telmisartan.

Ürün özellikleri

MICARDIS PI0072-21
1
AUSTRALIAN PRODUCT INFORMATION – MICARDIS
 (TELMISARTAN) TABLETS
1 NAME OF THE MEDICINE
telmisartan
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
MICARDIS is available as tablets for oral administration. Tablets
containing 40 mg and 80 mg of
telmisartan are available.
For the full list of excipients, see Section 6.1 List of excipients.
3 PHARMACEUTICAL FORM
MICARDIS
tablets are white to off-white, oblong tablets. MICARDIS
40 mg tablets have one face
marked with 51H and the other with the Boehringer Ingelheim company
symbol. MICARDIS
80
mg tablets have one face marked with 52H and the other with the
Boehringer Ingelheim company
symbol.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
MICARDIS is indicated for:
•
Treatment of hypertension in adults
•
Prevention of cardiovascular morbidity and mortality in adults 55
years or older with
coronary artery disease, peripheral artery disease, previous stroke,
transient ischaemic
attack or high risk diabetes with evidence of end organ damage (see
Section 5.1
Pharmacodynamic Properties, Clinical trials)
4.2 DOSE AND METHOD OF ADMINISTRATION
MICARDIS is available as tablets for oral administration.
MICARDIS
may be administered with or without food.
TREATMENT OF HYPERTENSION:
_Adults_: The recommended dose is 40 mg once daily. In cases where the
target blood pressure is
not achieved, telmisartan dose can be increased to 80 mg once daily.
When considering raising
the dose, it must be borne in mind that, while reduction in blood
pressure is achieved after the first
dose, the maximum antihypertensive effect is generally attained four
to eight weeks after the start
of treatment. Telmisartan may be used in combination with
thiazide-type diuretics such as
hydrochlorothiazide or calcium-channel blockers such as amlodipine,
which have been shown
to have an additive blood pressure lowering
effect with telmisartan.
PREVENTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY:
The recommended dose is 80 mg once daily. It is not known whether
doses lower than 80 mg o